NKGEN BIOTECH INC (NKGNW)
Institutional ownership reported to the SEC as of Q1 2025, across 7 quarters.
2
Reporting holders
$13.1K
Reported value
0.0%
Held as options
-23
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| RIVERNORTH CAPITAL MANAGEMENT, LLC | $13.1K | 652,432 | 0.00% | 6q | HELD |
| Mint Tower Capital Management B.V. | $1 | 40,000 | 0.00% | 6q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2025 | 2 | $13.1K | 692,432 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 25 | $263.8K | 2,603,537 | 2 | 1 | 3 | 1.2% |
| Q3 2024 | 28 | $157.6K | 2,198,221 | 1 | 4 | 3 | 1.4% |
| Q2 2024 | 30 | $222.7K | 2,288,635 | 1 | 3 | 2 | 1.2% |
| Q1 2024 | 30 | $345.9K | 2,353,130 | 4 | 1 | 4 | 1.4% |
| Q4 2023 | 32 | $199.3K | 2,499,547 | 31 | 1 | 0 | 1.2% |
| Q3 2023 | 1 | $37.2K | 94,254 | 1 | 0 | 0 | 0.0% |